Cordis names Alan Tsai as GM of Greater China region

Cordis today announced it appointed Alan Tsai as general manager of its Greater China region.

Tsai will head the leadership team that is responsible for strategic planning, business operation and team development in the Greater China region. He will be based in Shanghai and report directly to Bryan Loo, President of Cordis Asia Pacific.

Tsai has more than 15 years of sales and management experience in the medical device industry. He joined Cordis in 2014 as marketing director. Prior to joining the company, he was responsible for m marketing and sales across different positions at Johnson & Johnson MedTech.

“I am pleased that Alan is promoted as GM for Greater China. He has leveraged his extensive living and working experience in the United States (as well as countries across the Asia-Pacific region) to help the vast expansion of Cordis Greater China. He has made remarkable achievements in managing the team and accelerating continuous business growth. In the future, I am confident that he will lead the Cordis Greater China team to enhance their research and innovation, open up a new era, and provide Chinese doctors and patients with a healthy and enjoyable new life under his excellent leadership,” Loo said in a news release.

From 2018 to 2020, Tsai was responsible for marketing the Cordis portfolio and oversaw the patient rehabilitation business acquired from Medtronic. He has also led the company’s peripheral vascular unit since July 2020 and has led the team to achieve double-digit growth annually.

“I am more than honored to be a member of our innovative Cordis team. Adhering to our spectacular brand value, I will lead the team of Cordis Greater China to enhance our existing product portfolio and accelerate localization in China. Meanwhile, I will develop and enhance our local team, continue to bring innovative and efficient medical solutions in the field of vascular intervention to China, providing enhanced healthcare services for Chinese doctors and patients, and explore the new era for interventional procedures,” Tsai said. .

Source link

Leave a Comment

Your email address will not be published.